Category: SONN
-
SONN hits 52-week low, trading at 0.82 USD By Investing.com
•
Sonnet BioTherapeutics Holdings (NASDAQ:), Inc. stock recently hit a 52-week low, trading at $0.82. This represents a significant decline for the biopharmaceutical company that specializes in developing innovative targeted biologic medicines. The 52-week low of $0.82 is a stark contrast to its past performance. Over the past year, the company…